​

Nuvalent (NUVL) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

NUVL Stock Forecast

Nuvalent (NUVL) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $117.00, with a high of $134.00 and a low of $100.00. This represents a 63.32% increase from the last price of $71.64.

$65 $79 $93 $107 $121 $135 High: $134 Avg: $117 Low: $100 Last Closed Price: $71.64

NUVL Stock Rating

Nuvalent stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 10 Strong Sell Sell Hold Buy Strong Buy

NUVL Price Target Upside V Benchmarks

TypeNameUpside
StockNuvalent63.32%
SectorHealthcare Stocks 35.94%
IndustryBiotech Stocks 83.61%

Price Target Trends

1M3M12M
# Anlaysts--6
Avg Price Target--$114.83
Last Closing Price$71.64$71.64$71.64
Upside/Downside--60.29%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2539---12
Mar, 25581--14
Feb, 25581--14
Jan, 25581--14
Dec, 24581--14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 13, 2024Etzer DaroutBMO Capital$134.00$69.9991.46%87.05%
Oct 24, 2024David DaiUBS$100.00$93.716.71%39.59%
Sep 16, 2024Kelsey GoodwinGuggenheim$105.00$110.25-4.76%46.57%
Sep 16, 2024Bradley CaninoStifel Nicolaus$135.00$87.4554.37%88.44%
Sep 16, 2024Christopher RaymondRaymond James$100.00$87.4514.35%39.59%
Jul 10, 2024Bradley CaninoStifel Nicolaus$115.00$73.6356.19%60.52%
Apr 17, 2024Roger SongJefferies$97.00$64.7549.81%35.40%
Apr 01, 2024Christopher LiuLeerink Partners$110.00$75.0946.49%53.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 30, 2024H.C. WainwrightBuyinitialise
Nov 13, 2024BMO CapitalOutperformOutperformhold
Oct 24, 2024UBSNeutralinitialise
Sep 16, 2024GuggenheimBuyBuyhold
Sep 16, 2024Cowen & Co.BuyBuyhold
Sep 16, 2024WedbushOutperformOutperformhold
Sep 16, 2024Piper SandlerOverweightOverweighthold
Sep 16, 2024BMO CapitalOutperformOutperformhold
Aug 29, 2024BarclaysOverweightinitialise
Apr 17, 2024JefferiesBuyinitialise

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.17$-3.93----
Avg Forecast$-2.15$-3.91$-4.51$-4.77$-2.80$-0.70
High Forecast$-2.08$-3.53$-3.96$-2.88$-0.50$-0.70
Low Forecast$-2.21$-4.21$-5.52$-6.59$-5.19$-0.70
Surprise %0.93%0.51%----

Revenue Forecast

$0 $80M $160M $240M $320M $400M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$6.25M$36.55M$217.26M$365.44M
High Forecast--$6.25M$37.08M$217.26M$365.44M
Low Forecast--$6.25M$36.01M$217.26M$365.44M
Surprise %------

Net Income Forecast

$-400M $-320M $-240M $-160M $-80M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-126.22M$-260.76M----
Avg Forecast$-126.22M$-224.28M$-312.31M$-330.80M$-237.45M$-40.58M
High Forecast$-120.93M$-205.28M$-230.42M$-167.53M$-28.96M$-40.58M
Low Forecast$-128.56M$-245.39M$-321.42M$-383.72M$-302.26M$-40.58M
Surprise %-16.26%----

NUVL Forecast FAQ

Is Nuvalent stock a buy?

Nuvalent stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Nuvalent is a favorable investment for most analysts.

What is Nuvalent's price target?

Nuvalent's price target, set by 10 Wall Street analysts, averages $117 over the next 12 months. The price target range spans from $100 at the low end to $134 at the high end, suggesting a potential 63.32% change from the previous closing price of $71.64.

How does Nuvalent stock forecast compare to its benchmarks?

Nuvalent's stock forecast shows a 63.32% upside, outperforming the average forecast for the healthcare stocks sector (35.94%) and underperforming the biotech stocks industry (83.61%).

What is the breakdown of analyst ratings for Nuvalent over the past three months?

  • April 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 35.71% Strong Buy, 57.14% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 35.71% Strong Buy, 57.14% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.

What is Nuvalent’s EPS forecast?

Nuvalent's average annual EPS forecast for its fiscal year ending in December 2025 is $-4.51, marking a 14.76% increase from the reported $-3.93 in 2024. Estimates for the following years are $-4.77 in 2026, $-2.8 in 2027, and $-0.7 in 2028.

What is Nuvalent’s revenue forecast?

Nuvalent's average annual revenue forecast for its fiscal year ending in December 2025 is $6.25M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $36.55M, followed by $217.26M for 2027, and $365.44M for 2028.

What is Nuvalent’s net income forecast?

Nuvalent's net income forecast for the fiscal year ending in December 2025 stands at $-312M, representing an 19.77% increase from the reported $-261M in 2024. Projections indicate $-331M in 2026, $-237M in 2027, and $-40.576M in 2028.